BOTHELL, Wash., April 30, 2026 (GLOBE NEWSWIRE)-- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that the mechanism of action and clinical advancement of its first oral ...

Vaxart Inc., in collaboration with researchers from multiple academic institutions, evaluated the VXA-G1.1-NN vaccine against norovirus infection. Findings show a 30% reduction in infection rates ...

Norovirus, the infamous "winter vomiting disease," is surging again across the United States. Norovirus is a highly contagious stomach bug that causes sudden, often violent bouts of diarrhea and ...

The Centers for Disease Control and Prevention reported double the cases of norovirus compared to previous years in early December after outbreaks have been reported across the country. During the ...

With cases of norovirus surging in parts of the United States this winter, according to data from to the Centers for Disease Control and Prevention, how can you protect yourself and your family from ...

Ongoing Phase 1b human challenge study with oral, direct-acting protease inhibitor is designed to demonstrate proof-of-concept as a preventive and a treatment Fully enrolled first cohort is assessing ...

There are no approved treatments or vaccines for norovirus, the leading cause of acute gastroenteritis across all age groups and geographies with a $60 billion annual economic burden FDA Fast Track ...